Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 402-370-2 | CAS number: 149057-70-5 AOC 1020X
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1987
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1981
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- (ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised
- EC Number:
- 402-370-2
- EC Name:
- (ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised
- Cas Number:
- 149057-70-5
- Molecular formula:
- C14H28AlNO6
- IUPAC Name:
- octaaluminium(3+) octakis((2Z)-4-ethoxy-4-oxobut-2-en-2-olate) octakis(1-methoxypropan-2-olate) octakis(2-(dimethylamino)ethan-1-olate)
- Reference substance name:
- 1-methoxypropan-2-ol
- EC Number:
- 203-539-1
- EC Name:
- 1-methoxypropan-2-ol
- Cas Number:
- 107-98-2
- Molecular formula:
- C4H10O2
- IUPAC Name:
- 1-methoxypropan-2-ol
- Test material form:
- liquid
- Details on test material:
- purified with vacum distillation, analyzed by Gel permeation chromatography as stated in one of the study reports
Constituent 1
impurity 1
Test animals
- Species:
- mouse
- Strain:
- other: albino CFLP
- Details on species / strain selection:
- Seventy-seven male and seventy-seven female albino CFLP strain mice were supplied by Interfauna (UK) Limited, Wyton, Huntingdon, Cambridgeshire . At the start of the main study the males weighed 24 - 28g, and the females 24 - 28g, and were approximately five to eight weeks old. After a minimum acclimatisation period of five days the animals were selected at random and given a unique number within the study by ear punching and a number written on a colour coded cage card.
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- The animals were housed in groups of up to five by sex in solid-floor polypropylene cages with sawdust bedding. With the exception of a 3-4 hour fast immediately before dosing and for approximately two hours after dosing, free access to mains drinking water and food (Rat and Mouse Expanded Diet No. 1, Special Diet Services Limited, Witham, Essex, U.K.) was allowed throughout the study. The animal room was maintained at a temperature of 19 - 22°C and relative humidity of 60 - 68t. The rate of air exchange was approximately 15 changes per hour and the lighting was controlled by a time switch to give 12 hours light and 12 hours darkness.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Oil Arachi s B .P.
- Details on exposure:
- All animals were dosed once only at the appropriate dose level by gav-age using a metal cannula attached to a graduated syringe.
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Positive control(s):
- Cyclophosphamide Monohydrate
Examinations
- Tissues and cell types examined:
- bone marrow
- Details of tissue and slide preparation:
- Immediately following sacrifice (i.e. 24, 48 or 72 hours following dosing), one femur was dissected from each animal, aspirated with foetal calf serum (Flow Laboratories Ltd} and bone marrow smears prepared following centrifugation and re-suspension. The smears were air-dried, fixed in absolute methanol, defatted in xylene and stained in Leishman/Giemsa.
- Evaluation criteria:
- Evaluation of Slides
Stained bone marrow smears were examined at random using light micro-scopy at x 1000 magnification. The incidence of micronucleated cells per 1000 polychromatic erythrocytes (blue stained immature cells) per animal was scored. In addition, the number of normochromatic erythro-cytes (pink stained mature cells) associated with 1000 polychromatic erythrocytes were counted; these cells were also scored for incidence of micronuclei.
The ratio of·normochromatic to polychromatic erythrocytes was calcul-ated together with appropriate group mean values for males and females separately and combined.
Interpretation of Results
A comparison was made between the number of micronucleated polychromatic erythrocytes occuring in each of the three test material groups and the number occuring in the corresponding vehicle control groups. A positive mutagenic response is demonstrated when a statistically significant increase in the number of micronucleated polychromatic erythrocytes is observed for either the 24, 48 or 72 hour kill times. If the above criteria is not demonstrated, the test material is considered to be non-mutagenic under the conditions of the test.
A positive response for bone marrow toxicity is demonstrated when the treatment group mean normochromatic to po1ychromatic ratio is twice the vehic1e control value or when a treatment related increase is
shown to be statistically significant. - Statistics:
- All data were statistically analysed using the Kruskal-Wallis one-way analysis of variance by ranks (Kruskal W.H. and Wallis W.A. 1952 J. Arn. Statist. Soc. 47 583); when this was significant (P < 0.05) paired comparisons were made using the Mann-Whitney U-test
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Remarks:
- see vehicle control
- Positive controls validity:
- valid
- Additional information on results:
- Most animals treated with greater than 3000 mg/kg SA2/l/0A showed one or more clinical symptoms such as: hunched posture, pilo-erection, lethargy. decreased respiratory rate and ptosis, one and four hours after dosing. All surviving animals recovered and were normal on days one to three.
Based on the mortality data and clinical observations seen in the range-finding toxicity study a dose level of 5000 mg/kg was selected as a suitable "maximum tolerated dose" for the micronucleus study; being the highest dose level where no deaths were likely to occur.
Applicant's summary and conclusion
- Conclusions:
- In an OECD 474 micronucleus assay in mice, the test material, SA2/1/0A, was found not to produce micronuclei in polychromatic erythrocytes of mice under the conditions of the test.
- Executive summary:
In an OECD 474 micronucleus assay in mice, the test material, SA2/1/0A, was found not to produce micronuclei in polychromatic erythrocytes of mice under the conditions of the test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.